# Adcytherix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adcytherix

- Industry: Biotechnology
- Headquarters: Marseille, France
- Website: www.adcytherix.com
- Total disclosed funding: $155M
- Latest round: Series A (Oct 3, 2025)
- Investors on record: 10

## About

Founded in 2023 and based in Marseille, France by co-founder Jack Elands, Pontifax Venture Capital with Xavier Preville and Carsten Dehning, Adcytherix SAS operates as a biopharmaceutical company developing novel antibody drugs for treating diseases such as cancer. In October 2025, Adcytherix SAS raised EUR 105 million in series A funding co-led by new investors Bpifrance Investissement, Kurma Partners, Andera Partners, and Angelini Ventures, with participation from other new investors Surveyor Capital, and aMoon. Returning investors Pontifax Venture Capital, Dawn Biopharma, Pureos Bioventures, RA Capital Management, and other unspecified investors also participated in the round.

Adcytherix SAS specializes in the development of antibody-drug conjugates (ADCs), to target cancer therapies that combine monoclonal antibodies with cytotoxic drugs. The company’s approach aims to improve cancer treatment by targeting cancer cells while sparing healthy tissues. Its pipeline focuses on developing ADCs designed to improve therapeutic outcomes for patients with various types of cancer. 

The company plans to utilize the October 2025 funding to advance ADCX-020 into clinical trials and expand its portfolio of proprietary ADC programs.

## Funding rounds

- Series A, Oct 3, 2025, $123M — Andera Partners, Pontifax Venture Capital, Kurma Partners, Surveyor Capital, RA Capital Management, Bpifrance Investissement, aMoon, Pureos Bioventures, Angelini Ventures, Dawn Biopharma
- Seed, Apr 24, 2024, $32M — Pontifax Venture Capital, RA Capital Management, Pureos Bioventures, Dawn Biopharma

## Investors

- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Seed, Series A
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Seed, Series A
- Pureos Bioventures (https://capitalatlas.ai/funds/pureos-bioventures) — Seed, Series A
- Dawn Biopharma — Seed, Series A
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series A
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series A
- Surveyor Capital — Series A
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series A
- aMoon (https://capitalatlas.ai/funds/amoon) — Series A
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series A